Comments on "Impact of delay of diagnosis of pyoderma gangrenosum on healing outcomes and healthcare utilization: a prospective cohort study" [0.03%]
关于“诊断延迟对脓疱性瘭疽愈合结局和医疗保健利用影响的前瞻性队列研究”的评论
Peng-Yu Chen,Sui-Qing Cai,Zhuang-Li Tang
Peng-Yu Chen
Ethical Considerations in the Treatment of Frontal Fibrosing Alopecia: Addressing a Patient's Preference for Hair Transplant Over Medical Management [0.03%]
frontal fibrosing alopecia的治疗中的伦理考量：如何应对患者倾向于进行毛发移植而非药物治疗的意愿
Priya Agarwal,Gaurav N Pathak,Babar Rao
Priya Agarwal
High rates of potentially unnecessary topical antifungal prescribing in a large commercial health insurance claims database, United States [0.03%]
美国大型商业健康保险索赔数据库中高频率的可能不必要的外用抗真菌药物处方率
Jeremy A W Gold,Kaitlin Benedict,Avrom S Caplan et al.
Jeremy A W Gold et al.
Response to "Comments on "Impact of delay of diagnosis of pyoderma gangrenosum on healing outcomes and healthcare utilization: a prospective cohort study"" [0.03%]
对“关于“诊断延迟对脓疱性皮炎和坏死性皮肤病愈合结局和医疗利用率的影响：前瞻性队列研究”的评论”的回应
Olivia M Haddadin,Emile Latour,Alex G Ortega-Loayza
Olivia M Haddadin
Effect of Finger Socks on Clinical Cure in Interdigital Tinea Pedis [0.03%]
指间足癣临床治愈的疗效观察及断药后复发评价临床试验——研究方案
Hasan Aksoy,Mehmet Salih Gurel,Abdurrahman Sarmis et al.
Hasan Aksoy et al.
Background: Humidity between the toes and occlusion are risk factors and causes of recurrence for interdigital tinea pedis. Objective: ...
Dupilumab and neuropsychiatric outcomes in pediatric atopic dermatitis: a real-world cohort analysis [0.03%]
杜普利尤单抗与儿童特应性皮炎患者的神经精神结局：真实世界队列分析
Maria Kaltchenko,Sarah Radtke,Elle Kim et al.
Maria Kaltchenko et al.
Occupational formalin exposure from biopsy jars can be minimized by a modified collection procedure [0.03%]
改进的采集程序可以减少活检瓶中甲醛的职业暴露量
Julia Aires,Viseslav Tonkovic-Capin,M Laird Forrest
Julia Aires
Managing Skin Cancer in Solid Organ Transplant Recipients: Ethical Considerations [0.03%]
器官移植受者皮肤癌的管理：伦理考量
Eva Shelton,Sultan Qiblawi,George Zakhem et al.
Eva Shelton et al.
Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review [0.03%]
生物制剂失败的银屑病患者接受Bimekizumab治疗的疗效和安全性：一项52周多中心回顾性研究
Siddhartha Sood,Alexander Rimke,Brian D Rankin et al.
Siddhartha Sood et al.